Veeva encouraged to tap CRO industry after inVentiv puts head in the cloud
Veeva Systems has reported a robust Q3 strengthened by increasing interest in its cloud-based clinical trial management software and a deal with inVentiv Health.
Archives for November 26, 2014
US politicians plan fast-track vouchers to reward Ebola R&D
Bipartisan bills introduced in the US House of Representatives and the Senate would give manufacturers of Ebola therapies vouchers to speed up review of a drug of their choice.
Orphan drug CROs look to capitalize on influx of biotech cash
As small biotech companies continue to cash in on new investments, IPOs and increasing approval rates of orphan and rare disease drugs, CROs are cashing in too and helping the companies navigate the regulatory and clinical landscape.
Analyst: Parexel book-to-bill worries will be short-lived
Last quarter’s disappointing book-to-bill ratio for Parexel, which sent the CRO’s shares down about 15% will be short term, according to an analyst.
Why cashews and coconuts are Merck's green energy secret
Merck KGaA will run its manufacturing plant in Goa on fuel from cashews and coconuts.
Chinese excipient market set to more than double by 2017
With more than 90 excipient manufacturers in China dedicated to the pharma industry, the country expects its output of excipients to more than double to about $8.9bn (€7.1bn), according to a new report.